GLP Toxicology CROs

25 contract research organizations in our directory list GLP Toxicology as a capability, across 11 countries. 25 report GLP capability and 6 report AAALAC accreditation. Compare their species, services and accreditations below, and contact labs directly from their profiles.

25 CROs 25 GLP 6 AAALAC 11 countries

About GLP Toxicology

GLP toxicology studies are run under Good Laboratory Practice regulations (21 CFR Part 58 in the US, or OECD GLP principles) and form the core of an IND or CTA safety package. The GLP framework governs study conduct, documentation, quality assurance and archiving, so regulators can rely on the data.

When comparing labs, look beyond the GLP claim to recent regulatory inspection history, capacity in your species, and how the study director and QA unit handle protocol deviations.

GLP toxicology guide →

GLP Toxicology CROs

Showing 25 CROs. Order rotates daily so no lab is permanently listed first.

Accelera

IT GLP AAALAC

Non-clinical CRO near Milan and part of the NMS Group, offering GLP safety assessment and toxicology, safety pharmacology and preclinical regulatory consulting to move candidates toward IND/CTA.

GLP Toxicology Regulatory Support Repeat-Dose Toxicity Safety Pharmacology Toxicokinetics Dog Mouse Rabbit Rat

Sequani

GB GLP

Independent UK preclinical CRO offering GLP general, reproductive and juvenile toxicology studies for pharmaceutical and biotech sponsors.

GLP Toxicology Dermal Toxicity Juvenile Toxicity Repeat-Dose Toxicity Reproductive Toxicity Dog Minipig Rabbit Rat

Aurigon

HU GLP

Preclinical CRO with GLP laboratories near Budapest and offices in Munich, offering safety assessment, ADME-PK, bioanalysis and pharmacodynamic models.

GLP Toxicology Bioanalysis Immunotoxicology Pharmacokinetics Safety Pharmacology Dog Minipig Mouse Rabbit

CorestemChemon (ChemOn)

KR GLP AAALAC

South Korea's first private non-clinical CRO, providing GLP toxicity, safety pharmacology, pharmacokinetic and efficacy studies for drugs, chemicals and biologics.

GLP Toxicology In Vivo Efficacy Pharmacokinetics Repeat-Dose Toxicity Safety Pharmacology Dog Mouse Rabbit Rat

Agilex Biolabs

AU GLP

Australian bioanalytical and toxicology CRO with OECD GLP labs, supporting nonclinical toxicology and clinical bioanalysis.

GLP Toxicology Bioanalysis Immunogenicity Testing Toxicokinetics Mouse Rat

LPT Laboratory of Pharmacology and Toxicology

DE GLP

Independent German preclinical CRO conducting GLP toxicology, reproductive toxicology, carcinogenicity and safety pharmacology studies across rodent and non-rodent species.

GLP Toxicology Carcinogenicity Studies Repeat-Dose Toxicity Reproductive Toxicity Safety Pharmacology Dog Minipig Mouse Non-human Primate

Vivo Bio Tech

IN GLP

Hyderabad-based preclinical CRO offering GLP toxicology, pharmacology and pharmacokinetic studies across rodent and non-rodent species.

GLP Toxicology In Vivo Efficacy Pharmacokinetics Toxicology Dog Mouse Non-human Primate Rabbit

DT&CRO

KR GLP

Korean CRO covering GLP toxicity, PK and efficacy studies through to clinical trials for drugs, devices and other products.

GLP Toxicology Bioanalysis In Vivo Efficacy Medical Device Testing Pharmacokinetics Dog Mouse Rabbit Rat

Toxi-Coop

HU GLP

Hungarian non-clinical CRO founded in 1982 offering GLP general, genetic and reproductive toxicology for pharmaceutical, chemical and agrochemical sponsors.

GLP Toxicology Acute Toxicity Genetic Toxicology Reproductive Toxicity Dog Mouse Rabbit Rat

Eurofins Advinus

IN GLP

Bengaluru-based preclinical CRO, part of Eurofins, offering GLP safety assessment, DMPK and discovery services for pharmaceutical and agrochemical sponsors.

GLP Toxicology Genetic Toxicology Pharmacokinetics Repeat-Dose Toxicity Reproductive Toxicity Dog Mouse Rabbit Rat

Research Toxicology Centre (RTC)

IT GLP

Italian GLP CRO near Rome providing regulatory toxicology and safety studies for pharmaceuticals, chemicals and agrochemicals.

GLP Toxicology Genetic Toxicology Repeat-Dose Toxicity Reproductive Toxicity Dog Mouse Rabbit Rat

Shin Nippon Biomedical Laboratories (SNBL)

JP GLP

Long-established Japanese CRO with large GLP nonclinical safety facilities and deep nonhuman primate experience, supporting toxicology, safety pharmacology and pharmacokinetics.

GLP Toxicology Pharmacokinetics Repeat-Dose Toxicity Reproductive Toxicity Safety Pharmacology Cynomolgus monkey Dog Non-human Primate Rat

BoZo Research Center

JP GLP

Long-established Japanese preclinical CRO providing toxicology, carcinogenicity, genetic toxicity and pharmacology studies.

GLP Toxicology Carcinogenicity Studies Genetic Toxicology Pharmacokinetics Minipig Mouse Rat

Alpha Genesis

US GLP AAALAC

Vertically integrated nonhuman primate CRO in South Carolina combining on-site breeding with discovery pharmacology, GLP toxicology, vaccine and gene therapy studies.

GLP Toxicology Gene Therapy Studies In Vivo Efficacy Pharmacokinetics Vaccine Development Cynomolgus monkey Mouse Non-human Primate Rat

InnoStar

CN GLP AAALAC

Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.

GLP Toxicology Bioanalysis Biomarker Analysis Cell Therapy Gene Therapy Studies Dog Mouse Non-human Primate Rat

Palamur Biosciences

IN GLP

Indian GLP-certified preclinical CRO providing toxicology and safety studies.

GLP Toxicology Pharmacokinetics Toxicology Dog Mouse Rabbit Rat

Jai Research Foundation (JRF)

IN GLP

Indian GLP CRO providing regulatory toxicology and safety studies for pharmaceuticals, agrochemicals, chemicals and biologics.

GLP Toxicology Genetic Toxicology Repeat-Dose Toxicity Reproductive Toxicity Toxicology Dog Mouse Rabbit Rat

Biotoxtech

KR GLP AAALAC

Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.

GLP Toxicology Carcinogenicity Studies Genetic Toxicology Repeat-Dose Toxicity Reproductive Toxicity Dog Mouse Non-human Primate Rabbit

Nihon Bioresearch

JP GLP

Japanese preclinical CRO offering GLP safety and efficacy studies for drugs, devices and regenerative products, with long minipig experience.

GLP Toxicology In Vivo Efficacy Infectious Disease Models Medical Device Testing Safety Pharmacology Minipig Mouse Rabbit Rat

SAFE Pharma (Beijing Saifu)

CN GLP

Beijing-based preclinical CRO focused on GLP safety evaluation, with branches across China and support for biologics, nucleic acid and cell and gene therapies.

GLP Toxicology Gene Therapy Studies Pharmacokinetics Safety Pharmacology Dog Non-human Primate Rat

Scantox

DK GLP

GLP-accredited preclinical CRO headquartered in Denmark with sites in Sweden, Austria and the UK. Known for Gottingen minipig work and regulatory toxicology, with discovery pharmacology including CNS and…

GLP Toxicology CNS Disease Models Dermal Toxicity Formulation Development Genetic Toxicology Minipig Mouse Rabbit Rat

Korea Institute of Toxicology (KIT)

KR GLP

Government-funded Korean research institute providing GLP nonclinical safety studies, including inhalation toxicology, safety pharmacology and reproductive toxicity.

GLP Toxicology Inhalation Toxicity Repeat-Dose Toxicity Reproductive Toxicity Safety Pharmacology Dog Mouse Non-human Primate Rat

Bioneeds

IN GLP AAALAC

OECD GLP-certified preclinical CRO near Bengaluru providing regulatory toxicology for pharmaceuticals, biologics, devices and chemicals.

GLP Toxicology Genetic Toxicology Immunogenicity Testing Medical Device Testing Toxicology Guinea Pig Mouse Rabbit Rat

K-Prime Research (BTT Group)

KR GLP

Korean nonhuman primate CRO in the Biotoxtech group with GLP repeat-dose toxicity and cardiovascular safety pharmacology in NHPs, plus NHP inhalation studies.

GLP Toxicology Cardiovascular Safety Inhalation Toxicity Repeat-Dose Toxicity Safety Pharmacology Cynomolgus monkey Non-human Primate

Questions to ask when choosing a GLP Toxicology CRO

  • When was your most recent FDA or OECD GLP inspection, and were there findings?
  • Which species and routes do you routinely run under GLP?
  • Who will be the study director, and how many concurrent studies do they carry?